NeurosciencebioRxivPreprint
Long term rescue of Alzheimer deficits in vivo by one-time gene-editing of App C-terminus.
Brent D. Aulston, Kirstan Gimse, Hannah Bazick…·Subhojit Roy
The paper uses CRISPR-Cas9 to edit the App gene in mice, reducing Alzheimer's disease symptoms and showing long-term benefits.
3 citations